2-(3-(3-((5-Ethyl-4'-Fluoro-2-Hydroxy-[1,1'-Biphenyl]-4-Yl)Oxy)Propoxy)-2-Propylphenoxy)Benzoic Acid 2-(3-(3-((5-乙基-4'-氟-2-羟基-[1,1'-联苯]-4-基)氧基)丙氧基)-2-丙基苯氧基)苯甲酸
CAS 161172-51-6 MFCD61172516
化学结构图
SMILES: CCCc1c(OCCCOc2cc(O)c(-c3ccc(F)cc3)cc2CC)cccc1Oc1ccccc1C(=O)[O-].[Na+]
化学属性
| Mol. Weight | 566.59 |
|---|---|
| Appearance | Solid powder |
| Solubility | Soluble in DMSO, not in water |
别名和识别编码
| Chemical Name | 2-(3-(3-((5-Ethyl-4'-Fluoro-2-Hydroxy-[1,1'-Biphenyl]-4-Yl)Oxy)Propoxy)-2-Propylphenoxy)Benzoic Acid |
|---|---|
| Chemicalbook ID | CB61856046 |
| Chemical Name Translation | 2-(3-(3-((5-乙基-4'-氟-2-羟基-[1,1'-联苯]-4-基)氧基)丙氧基)-2-丙基苯氧基)苯甲酸 |
| Formula | C33H32FNaO6 |
| Synonym | VML295; VML-295; VML 295; LY293111; LY-293111; LY 293111; PDSP1001237; PDSP2001221; Etalocib |
| IUPAC Name | sodium 2-(3-(3-((5-ethyl-4'-fluoro-2-hydroxy-[1,1'-biphenyl]-4-yl)oxy)propoxy)-2-propylphenoxy)benzoate |
| InChIKey | GKDIMGQSBSDJNC-UHFFFAOYSA-M |
| InChI | InChI=1S/C33H33FO6.Na/c1-3-9-25-29(12-7-13-30(25)40-31-11-6-5-10-26(31)33(36)37)38-18-8-19-39-32-21-28(35)27(20-22(32)4-2)23-14-16-24(34)17-15-23;/h5-7,10-17,20-21,35H,3-4,8-9,18-19H2,1-2H3,(H,36,37);/q;+1/p-1 |
| Canonical SMILES | O=C([O-])C1=CC=CC=C1OC2=CC=CC(OCCCOC3=C(CC)C=C(C4=CC=C(F)C=C4)C(O)=C3)=C2CCC.[Na+] |
信息真实价格透明
资金保障
专业采购外包团队在线服务
信息真实价格透明
资金保障
专业采购外包团队在线服务
品牌质保精细包装
现货库存
一流品牌服务
产品应用
- Etalocib, also known as LY293111 and VML295, is a novel diaryl ether carboxylic acid derivative, is a potent and selective inhibitor of the lipoxygenase pathway either directly through 5'-lipoxygenase or via antagonism of the leukotriene B4 (LTB4) receptor. LY293111 has antineoplastic activity in a variety of preclinical models.
